Boomers Should Not ...
Health Care: Drugs
NuPathe Inc. (PATH: NASDAQ)
$3.14 -0.01 | -0.32%
05/22/13 - 04:00 PM ET
Company Profile
| Price and Volume | |
|---|---|
| Recent Price | 3.14 |
| 52 Week High | 4.59 |
| 52 Week Low | 2.47 |
| Avg. Daily Vol. (Mil) | 0.16 |
| Beta (3 year) | 3.45 |
| Share Related Items | |
| Mkt Cap (Mil) | 97.57 |
| Shares Out (Mil) | 31.07 |
| Float (Mil) | 12.90 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 4.20 |
| Current Ratio | 4.30 |
| LT Debt/ Equity | 0.48 |
| Total Debt / Equity | 0.54 |
| Valuation Ratios | |
| Price Earnings | n.a. |
| Price/Sales | 0.00 |
| Price/Book | 6.34 |
| Price/Cash Flow | -2.30 |
| Per Share Data | |
| Earnings | -2.74 |
| Sales | 0.00 |
| Book Value | 0.50 |
| Cash Flow | -1.34 |
| Business Summary | |
|---|---|
| NuPathe Inc., is a biopharmaceutical company develops and commercializes branded therapeutics for diseases of the central nervous system, including neurological and psychiatric disorders. | |
| General Information | |
| 227 Washington Street
Suite 200 Conshohocken, PA 19428 |
|
| www.nupathe.com | |
| Industry : Drugs | |
| Sector: Health Care | |
| Employees: 14 | |
| CEO: Armando Anido | |
| Short Interest | |
| Current Month (Mil) | 0.89 |
| Previous Month (Mil) | 1.37 |
| Short Interest Ratio (Days) | 5.80 |
| Management Effectiveness | |
| Return on Equity | n.a. |
| Return on Assets | -155.20 |
| Return on Investments | -184.00 |
| Profitability | |
| Gross Margin | n.a. |
| EBIT Margin | n.a. |
| Profit Margin | 0.00 |
Portfolios with PATH
- Portfolio NameUser Type
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Setting Up...
- ContributorDrugs Facing FDA Approval i...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- ContributorEarnings Short Squeeze Play...
- ContributorUnder-$10 Setting Up To Tra...
- UserSMITTY
- ContributorHot Biotech Trades for Seco...
- Contributor9 Health Care Stocks With 1...
Latest PATH Headlines from TheStreet
- 4 Health Care Stocks Under $10 to Watch 04.16.13 | 03:04 pm
- 5 Under-$10 Stocks Primed to Trade Higher 12.20.12 | 12:12 pm
- 2013 FDA Drug Approval Decision Calendar 12.19.12 | 09:12 am
- First 90 Days of 2013 Are Live or Die For These Biotech Stocks 11.19.12 | 09:11 am
- 5 Biotech Stocks Under $5 Blasting Off 08.16.12 | 03:08 pm
- NuPathe Management Discusses Q2 2012 Results - Earnings Call Transcript 08.14.12 | 02:08 pm
- 4 Stocks Under $5 Making Big Moves 07.17.12 | 12:07 pm
- 8 Stocks Under $10 Moving Higher 02.08.12 | 02:02 pm
- 11 Stocks to Watch: NuPathe, Universal Display 08.30.11 | 08:08 am
- FDA Rejects NuPathe Migraine Patch 08.30.11 | 06:08 am
Press Releases for PATH
- Safeguard Scientifics Announces Second Quarter 2011 Financial Results - Business Wire 07.27.11 | 06:07 am
Partner Headlines for PATH
- Pre-Market Earnings Report for March 26, 2013 : NEOG, PLCE, PATH - NASDAQ 03.25.13 | 08:03 pm
- Morning Market Losers - Benzinga 09.26.12 | 09:09 am
- 7 Biotech Stocks Being Snapped Up By Insiders - Seeking Alpha 03.16.12 | 05:03 pm
- Why Antares Pharma Should Be On Your List For Long-Term Investment - Seeking Alpha 03.16.12 | 08:03 am
- NuPathe Announces Allowance of U.S. Patent Application for NP202 - Benzinga 02.29.12 | 04:02 pm
- Nupathe's Zelrix Going Down A Path With Multiple Headwinds - Seeking Alpha 12.09.11 | 09:12 am
- 5 Healthcare Stocks To Consider - Seeking Alpha 09.01.11 | 08:09 am
- Mid-Day Update: US Indexes Recover from Red; Consumer Confidence Data Still Weighs - NASDAQ 08.30.11 | 04:08 pm
- Stocks Recover from Consumer Confidence Data-Induced Slump; Commodities Trending Higher - NASDAQ 08.30.11 | 04:08 pm
- Morning Market Losers - Benzinga 08.30.11 | 09:08 am
